Combination of Cannabinoids, ?9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.

Combination of Cannabinoids, ?9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Front Immunol. 2019; 10:1921.

View in: PubMed

subject areas

Animals
Anti-Inflammatory Agents
Brain
Cannabidiol
Cells, Cultured
Cytokines
Dronabinol
Encephalomyelitis, Autoimmune, Experimental
Female
Leukocytes, Mononuclear
Mice, Inbred C57BL
Mice, Knockout
MicroRNAs
Multiple Sclerosis
Signal Transduction
Spinal Cord
Spleen

authors with profiles

Mitzi Nagarkatti